20th International Congress » Genetics (PD and Non-PD)

Date: Tuesday, June 21, 2016

Time: 12:30pm-2:00pm

Session Type: Guided Poster Tour

Meeting: 20th International Congress

12:30pm-2:00pm: De novo mutations in PDE10A cause childhood-onset chorea with bilateral striatal lesions

N.E. Mencacci, E.J. Kamsteeg, L. R'Bibo, D. Lynch, B. Balint, M. Willemsen, M. Adams, S. Wiethoff, J. Ng, E. Meyer, L. Veneziano, P. Giunti, D. Hughes, M. Carecchio, G. Zorzi, C. Barzaghi, B. Garavaglia, N. Nardocci, V. Salpietro, J. Hardy, A. Pittman, H. Houlden, M. Kurian, L. Vissers, N. Wood, K. Bhatia (Londond, United Kingdom)

12:30pm-2:00pm: Deletions at 22q11.2 in idiopathic Parkinson’s disease: A combined analysis of GWAS data

K.Y. Mok, U. Sheerin, J. Simón-Sánchez, A. Salaka, L. Chester, V. Escott-Price, K. Mantripragada, K.M. Doherty, A.J. Noyce, N.E. Mencacci, S.J. Lubbe, International Parkinson's Disease Genomics Consortium (IPDGC), C.H. Williams-Gray, R.A. Barker, K.D. van Dijk, H.W. Berendse, P. Heutink, J.C. Corvol, F. Cormier, S. Lesage, A. Brice, K. Brockmann, C. Schulte, T. Gasser, T. Foltynie, P. Limousin, K.E. Morrison, C.E. Clarke, S. Sawcer, T.T. Warner, A.J. Lees, H.R. Morris, M.A. Nalls, A.B. Singleton, J. Hardy, A.Y. Abramov, V. Plagnol, N.M. Williams, N.W. Wood (London, United Kingdom)

12:30pm-2:00pm: Effect of genetic variation in SNCA and APOE on cerebrospinal fluid protein levels in patients with Parkinson’s disease and controls

G. Machetanz, K. Lohmann, C.M. Lill, C. Klein, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)

12:30pm-2:00pm: Epigenome-wide association study of Parkinson’s disease

B. Ritz, Y.H. Chuang, S. Horvath, Y. Bordelon, J. Bronstein (Los Angeles, CA, USA)

12:30pm-2:00pm: Exome sequencing in dementia with Lewy bodies

S.W. Scholz, J.T. Geiger, J. Ding, B. Crane, O. Pletnikova, C. Letson, T.M. Dawson, L.S. Rosenthal, A. Pantelyat, J.R. Gibbs, M. Albert, D.G. Hernandez, A.E. Hillis, A.B. Singleton, D.J. Stone, J.A. Hardy, J.C. Troncoso (Bethesda, MD, USA)

12:30pm-2:00pm: Inflammatory profile discriminates clinical subtypes in LRRK2-associated PD

K. Brockmann, C. Schulte, N. Schneiderhan-Marra, A. Apel, C. Pont-Sunyer, D. Vilas, J. Ruiz-Martinez, M. Langkamp, J.C. Corvol, F. Cormier, T. Knorpp, T.O. Joos, A. Bernhard, T. Gasser, C. Marras, B. Schüle, J.O. Aasly, T. Foroud, J.F. Marti-Masso, A. Brice, E. Tolosa, D. Berg, W. Maetzler (Tübingen, Germany)

12:30pm-2:00pm: Intracranial calcifications in children and adults: Molecular and phenotypic characterization from a tertiary referral centre

C. Panteghini, M. Carecchio, D. Tonduti, C. Barzaghi, L. Magistrelli, A. Decio, L. Chiapparini, A. Pichiecchio, S. Esposito, C. Pantaleoni, D. Riva, I. Moroni, S. Orcesi, N. Nardocci, B. Garavaglia, Cerebral Calcification Study Group (Milan, Italy)

12:30pm-2:00pm: Lysosomal alterations in peripheral blood mononuclear cells of Parkinson’s disease patients

N. Papagiannakis, M. Xilouri, C. Koros, M. Stamelou, R. Antonelou, M. Maniati, D. Papadimitriou, M. Moraitou, H. Michelakakis, L. Stefanis (Chaidari, Greece)

12:30pm-2:00pm: Neuronal nicotinamide-N-methyltransferase (NNMT) in Parkinson’s disease

K. Schmeisser, A. Parker (Montreal, QC, Canada)

12:30pm-2:00pm: Substantial motor and non-motor symptoms in children and adults with classical galactosemia and organic acidurias

A. Kuiper, M.A. Coenen, W. Eggink, M.A.J. Tijssen, T.J. De Koning (Groningen, Netherlands)